A healthtech company creating 3D printing solutions for personalized medicine

By modernizing the drug compounding process in pharmacies, CurifyLabs enables sustainable, quality-controlled production of personalized medicine, customized to provide safe and effective treatment for all patients.

Team

Experienced team with decades of expertise in pharmacy and pharmaceutical technology and a track record of entrepreneurship

Technology

Proprietary, disruptive technology based on patented printable inks

FIELD TESTED

Technology developed together with innovative pharmacists on major European markets including Switzerland, Germany, Spain and the Netherlands

CurifyLabs was founded in 2021 with headquarters in Helsinki, Finland.

For pharmacists, by pharmacists

 

Having decades of experience in pharmacy and compounding technology, we understand the needs and pain points of pharmacy preparations. In addition to compounding itself, our deep understanding of the regulatory landscape ensures we are compliant while pushing the boundaries of innovation in the market.

From 1%

Currently just 1% of drugs are personalized through compounding

To 10%

We believe patient demand and technology can incerease this to as much as 10%

Patient demand

Under-served patient populations such as children and cancer patients, are expected to drive demand for a more tailored approach to medicine